SPIRIT Checklist for: Efficacy and safety of long acting injectable cabotegravir and rilpivirine in improving HIV-1 control in Sub Saharan Africa: Protocol for a phase 3b open label randomized controlled trial (IMPALA)
Tumusiime, V
, Ruzagira, E
, Norcross, C, Eshun-Wilsonova, I, Kitonsa, J, Bahemuka, UM, Grint, D
, Kimbugwe, G, Kakande, A, Lawrence, DS, Mwendia, F, Van Solinge, R, Van Eygen, V, Boateng, FA and Cresswell, F
(2025).
SPIRIT Checklist for: Efficacy and safety of long acting injectable cabotegravir and rilpivirine in improving HIV-1 control in Sub Saharan Africa: Protocol for a phase 3b open label randomized controlled trial (IMPALA).
[Dataset].
London School of Hygiene & Tropical Medicine, London, United Kingdom.
10.17037/DATA.00004492.
SPIRIT Checklist for a study protocol paper on Efficacy and safety of long acting injectable cabotegravir and rilpivirine in improving HIV-1 control in Sub Saharan Africa: Protocol for a phase 3b open label randomized controlled.
Keywords
Trial protocolItem Type | Dataset |
---|---|
Capture method | Summary |
Date | 13 January 2025 |
Language(s) of written materials | English |
Creator(s) |
Tumusiime, V |
LSHTM Faculty/Department | MRC/UVRI and LSHTM Uganda Research Unit |
Participating Institutions | London School of Hygiene & Tropical Medicine, London, United Kingdom |
Funders |
Project Funder Grant Number Funder URI IMPALA: Improving HIV Outcomes in Africa With Long Acting Antiretrovirals UNSPECIFIED https://doi.org/10.13039/100027026 |
Date Deposited | 13 Jan 2025 11:33 |
Last Modified | 12 Feb 2025 16:31 |
Publisher | London School of Hygiene & Tropical Medicine |
SPIRIT-Checklist-MPALA study.docx
-
subject - Documentation
- Creative Commons: Public Domain Dedication
- Available under Creative Commons: Public Domain Dedication
-
info - SPIRIT Checklist for MPALA study
description - application/vnd.openxmlformats-officedocument.wordprocessingml.document
- folder_info
- 57kB
Download this file
Share this file
Downloads
ORCID: https://orcid.org/0000-0001-9535-7640
ORCID: https://orcid.org/0000-0002-7291-1693
ORCID: https://orcid.org/0000-0001-8001-6544
ORCID: https://orcid.org/0000-0002-5070-532X